Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · GE HealthCare (GEHC)

GE HealthCare Q4 revenue rises 7.1%; Q4 diluted EPS falls to $1.29 from $1.57

Mixed Impact 3 of 5 earnings Written later

GE HealthCare reported fourth quarter and full year 2025 results on February 4, 2026, with revenue up in both periods. Fourth quarter diluted EPS fell to $1.29 from $1.57 as tariff expense weighed on profit, while full year diluted EPS rose to $4.55 from $4.34. The company also introduced 2026 guidance calling for adjusted EPS of $4.95 to $5.15.

Key points

  • Q4 2025 revenue of $5.7 billion, up 7.1%; organic revenue growth of 4.8%
  • Q4 diluted EPS of $1.29 versus $1.57; adjusted EPS of $1.44 versus $1.45
  • Full year 2025 revenue of $20.6 billion, up 4.8%; diluted EPS of $4.55 versus $4.34
  • 2026 guidance: adjusted EPS of $4.95 to $5.15 and free cash flow of approximately $1.7 billion; $2.3 billion Intelerad acquisition expected to close in first half of 2026

The filing

CompanyGE HealthCare (GEHC)
Form8-K, current report
Filed with the SECFeb 4, 2026, 6:25 AM ET
Accession number0001932393-26-000006

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.